Volume 120, Issue 1

Search all International Journal of Hematology articles

July 2024

Including PIH articles on Novel treatment strategies for hematological malignancies in the era of immune therapy

20 articles in this issue

Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus
Osamu Imataki
Haruyuki Fujita
Makiko Uemura
Images in Hematology 26 May 2024 Pages: 1 - 2
Novel treatment strategies for hematological malignancies in the immunotherapy era
Yoichi Imai
Progress in Hematology 11 June 2024 Pages: 3 - 5
Novel CAR T cell therapies for patients with large B cell lymphoma
Hideki Goto
Masahiro Onozawa
Takanori Teshima
Progress in Hematology 25 May 2024 Pages: 6 - 14
Current progress of CAR-T-cell therapy for patients with multiple myeloma
Takahiro Nakashima
Yuki Kagoya
Progress in Hematology 23 May 2024 Pages: 15 - 22
Bispecific antibodies for multiple myeloma: past, present and future
Toshiki Ochi
Tatsuya Konishi
Katsuto Takenaka
Progress in Hematology 13 April 2024 Pages: 23 - 33
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia
Yuta Kaito
Yoichi Imai
Progress in Hematology 01 May 2024 Pages: 34 - 43
A review of the Augustine blood group system
Jing Zhong
Chunping Mo
Lingbo Li
Review Article 20 May 2024 Pages: 44 - 49
Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia
Chendong Jiang
Shu Deng
Enwu Yuan
Original Article Open access 26 April 2024 Pages: 50 - 59
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group
Noriyoshi Iriyama
Eisaku Iwanaga
Tatsuya Kawaguchi
Original Article 08 April 2024 Pages: 60 - 70
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain
Hirono Iriuchishima
Akio Saito
Morio Matsumoto
Original Article 29 March 2024 Pages: 71 - 79
A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom’s macroglobulinemia
Koji Izutsu
Hisashi Kato
Ei Fujikawa
Original Article Open access 10 April 2024 Pages: 80 - 90
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma
Taku Kikuchi
Nobuhiro Tsukada
Tadao Ishida
Original Article 19 April 2024 Pages: 91 - 95
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas
Sha Zhou
Jun Rao
Li Gao
Original Article Open access 08 April 2024 Pages: 96 - 105
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial
Takanori Teshima
Yasushi Onishi
Makoto Onizuka
Original Article Open access 25 May 2024 Pages: 106 - 116
Clinical features of immature leukemias in children
Daichi Sajiki
Nao Yoshida
Asahito Hama
Original Article 30 April 2024 Pages: 117 - 127
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review
Wataru Kitamura
Hiroki Kobayashi
Shoichi Kuyama
Case Report 15 April 2024 Pages: 128 - 134
An unfavorable and a successful pregnancy outcome during and after treatment of gamma heavy chain disease
Masataka Hosoi
Kazunori Ueno
Takuro Watanabe
Case Report 18 April 2024 Pages: 135 - 141
Bernard–Soulier syndrome caused by a novel GP1BB variant and 22q11.2 deletion
Rintaro Nagoshi
Atsushi Sakamoto
Akira Ishiguro
Case Report 16 April 2024 Pages: 142 - 145
Post-transfusion purpura and adult primary thrombocytopenia
Philip Murphy
Letter to the Editor 29 April 2024 Pages: 146 - 146
Reply to the Dr. Murphy’s comment
Hirokazu Kashiwagi
Letter to the Editor 16 May 2024 Pages: 147 - 147

Volume 120, Issue 1

Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus

Novel treatment strategies for hematological malignancies in the immunotherapy era

Novel CAR T cell therapies for patients with large B cell lymphoma

Current progress of CAR-T-cell therapy for patients with multiple myeloma

Bispecific antibodies for multiple myeloma: past, present and future

Evolution of natural killer cell-targeted therapy for acute myeloid leukemia

A review of the Augustine blood group system

Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia

Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group

Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain

A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom’s macroglobulinemia

Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma

Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas

Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial

Clinical features of immature leukemias in children

Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review

An unfavorable and a successful pregnancy outcome during and after treatment of gamma heavy chain disease

Bernard–Soulier syndrome caused by a novel GP1BB variant and 22q11.2 deletion

Post-transfusion purpura and adult primary thrombocytopenia

Reply to the Dr. Murphy’s comment

Navigation